GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Glenmark Pharmaceuticals Ltd (NSE:GLENMARK) » Definitions » 5-Year Yield-on-Cost %

Glenmark Pharmaceuticals (NSE:GLENMARK) 5-Year Yield-on-Cost % : 0.32 (As of May. 05, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Glenmark Pharmaceuticals 5-Year Yield-on-Cost %?

Glenmark Pharmaceuticals's yield on cost for the quarter that ended in Dec. 2023 was 0.32.


The historical rank and industry rank for Glenmark Pharmaceuticals's 5-Year Yield-on-Cost % or its related term are showing as below:

NSE:GLENMARK' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.21   Med: 0.47   Max: 1.33
Current: 0.32


During the past 13 years, Glenmark Pharmaceuticals's highest Yield on Cost was 1.33. The lowest was 0.21. And the median was 0.47.


NSE:GLENMARK's 5-Year Yield-on-Cost % is ranked worse than
90.8% of 500 companies
in the Drug Manufacturers industry
Industry Median: 2.145 vs NSE:GLENMARK: 0.32

Competitive Comparison of Glenmark Pharmaceuticals's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Glenmark Pharmaceuticals's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glenmark Pharmaceuticals's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Glenmark Pharmaceuticals's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Glenmark Pharmaceuticals's 5-Year Yield-on-Cost % falls into.



Glenmark Pharmaceuticals 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Glenmark Pharmaceuticals is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Glenmark Pharmaceuticals  (NSE:GLENMARK) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Glenmark Pharmaceuticals 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Glenmark Pharmaceuticals's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Glenmark Pharmaceuticals (NSE:GLENMARK) Business Description

Traded in Other Exchanges
Address
Glenmark House, B. D. Sawant Marg, Chakala, Off Western Express Highway, Andheri (East), Mumbai, IND, 400099
Glenmark Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company's research and development activity is focused on generating intellectual property assets that will help address unmet medical needs. Glenmark's product categories include novel molecular entities, formulations, and API products. The company considers merger and acquisition investment to be a potential component for expanding its research, development, manufacturing, and marketing capabilities.

Glenmark Pharmaceuticals (NSE:GLENMARK) Headlines

No Headlines